Skip to main content
. Author manuscript; available in PMC: 2019 Jan 15.
Published in final edited form as: Int J Cancer. 2017 Sep 28;142(2):347–356. doi: 10.1002/ijc.31051

Table 1.

Results Summary

Case # Somatic Mutations Matches** Copy Number
Similarity/Rank***
Left Right Shared P-Value*
1 9 7 0 1.0 −1.78 / 43
2 3 3 0 1.0 0.76 / 20
3 2 7 0 1.0 0.57 / 22
4 8 10 0 1.0 −1.75 / 42
6 6 5 0 1.0 0.55/ 23
8 6 2 1 0.004 ARID1A E250fs 3.74 / 2
9 2 3 0 1.0 −1.16/ 35
12 14 3 0 1.0 −4.09 / 49
13 3 3 0 1.0 −0.22 / 28
15 8 5 0 1.0 −1.92 / 44
16 10 8 0 1.0 −2.65 / 47
17 6 8 0 1.0 −0.14/ 26
18 8 2 0 1.0 2.37 / 5
21 4 3 0 1.0 0.29 / 24
23 10 4 0 1.0 −1.47 / 40
24 4 3 0 1.0 1.76/ 8
25 4 6 0 1.0 −0.32 / 30
26 6 5 0 1.0 1.57 / 11
27 4 5 0 1.0 1.38 / 13
29 3 1 0 1.0 −0.28 / 29
30 6 5 0 1.0 −1.18 / 36
31 6 5 0 1.0 −1.21 / 37
32 5 4 0 1.0 −0.98 / 34
33 6 4 0 1.0 1.80 / 7
35 5 4 0 1.0 −0.01 / 25
36 3 4 3 <0.001 CDH1 S111fs; TBX3 T267fs; EPPK1 R2337H 4.46 / 1
38 8 2 0 1.0 −1.60 / 41
40 10 1 0 1.0 2.68 / 4
41 0 9 -- 1.0 1.12 / 17
43 4 4 0 1.0 −0.69 / 33
44 9 21 0 1.0 −2.32 / 46
45 3 4 0 1.0 1.24 / 15
48 2 3 2 <0.001 MLH3 M346R; MAP3K1 R248* 3.01 / 3
52 5 7 0 1.0 2.23 / 6
56 2 5 0 1.0 1.51 / 12
58 3 4 0 1.0 −1.25 / 38
59 2 3 0 1.0 0.83 / 19
62 4 4 0 1.0 −0.17 / 27
63 3 9 1 0.08 PIK3CA H1047R 0.98 / 18
64 5 4 0 1.0 0.63 / 21
66 33 3 0 1.0 1.34 / 14
67 4 1 1 0.08 PIK3CA H1047R 1.75 / 9
70 5 2 0 1.0 −2.95 / 48
71 3 1 0 1.0 1.21 / 16
72 1 3 0 1.0 −2.19 / 45
74 2 1 0 1.0 −0.66 / 32
75 4 3 1 0.08 PIK3CA H1047R −1.36 / 39
76 7 5 0 1.0 1.70 / 10
77 3 1 0 1.0 −0.60 / 31
*

P-value for the test of clonal relatedness of the tumor pair.

**

Matches were validated either by re-sampling the tumor and resequencing if sufficient tumor was available or by targeted sequencing (MiSeq), or by Sanger sequencing.

***

Log likelihood ratio measure of similarity of copy number profiles and ranking